Thomas D. Schmittgen
Thomas D. Schmittgen | |
|---|---|
| Born | 1959 (age 66–67) Lorain, Ohio, USA |
| Spouse |
Janet Wadolny (m. 1986) |
| Academic background | |
| Education | BSc, 1985, PhD, Pharmaceutics, 1992, Ohio State University |
| Thesis | Pharmacodynamics of antiproliferative agents in patient and rodent tumor explants (1992) |
| Academic work | |
| Institutions | University of Florida College of Pharmacy Ohio State University Washington State University |
Thomas Donald Schmittgen (born 1959) is an American pharmacologist. He is Chair of Pharmaceutics in the University of Florida College of Pharmacy. In 2020, Schmittgen was elected a Fellow of the American Association for the Advancement of Science for "distinguished contributions to the field of microRNA biology, particularly using real time PCR to quantify microRNA expression in tissues, extracellular vesicles, cell lines and tumors." In 2025, the journal Nature listed Schmittgen's 2001 publication as the second most-cited research article of the 21st century and the fifth most-cited publication of all time.
Early life and education
Schmittgen was born in 1959[1] to Donald Schmittgen in Lorain, Ohio.[2] He completed his Bachelor of Science and PhD in pharmaceutics at Ohio State University.[3]
Career
Following his PhD, Schmittgen served on the faculty at Washington State University's College of Pharmacy from 1995 to 2002. He then returned to his alma mater in 2002 as chair of the Division of Pharmaceutics.[3]
Schmittgen joined the faculty at the University of Florida College of Pharmacy in 2015 through the UF Preeminence Initiative.[3] As a professor of pharmaceutics, Schmittgen worked on identifying new ways to restore microRNA levels in cancer cells.[4] He was elected a Fellow of the American Association of Pharmaceutical Scientists in 2016 for his research on noncoding RNAs and cancer.[5] In 2018, Schmittgen was appointed chair of the department of pharmaceutics.[6] He was also named the V. Ravi Chandran Professor of Pharmaceutical Sciences in the University of Florida College of Pharmacy.[7] In 2020, Schmittgen was elected a Fellow of the American Association for the Advancement of Science for "distinguished contributions to the field of microRNA biology, particularly using real time PCR to quantify microRNA expression in tissues, extracellular vesicles, cell lines and tumors."[8] In 2025, the journal Nature listed Schmittgen's 2001 publication as the second most-cited research article of the 21st century and the fifth most-cited publication of all time.[9]
Personal life
Schmittgen married Janet Wadolny in 1986.[2]
References
- ↑ "Schmittgen, Thomas Donald, 1959". VIAF. Retrieved October 31, 2025.
- 1 2 "Schmittgen-Wadolny". The Morning Call. July 9, 1986. Retrieved October 31, 2025 – via newspapers.com.
- 1 2 3 "Thomas D Schmittgen, Ph.D." University of Florida. Retrieved October 31, 2025.
- ↑ Splett, Matthew (September 12, 2016). "UF Health researcher investigates natural treatment for liver cancer". University of Florida. Retrieved October 31, 2025.
- ↑ "Dr. Thomas Schmittgen elected AAPS Fellow". University of Florida. November 18, 2016. Retrieved October 31, 2025.
- ↑ "Dr. Tom Schmittgen appointed chair of the department of pharmaceutics". University of Florida. July 20, 2018. Retrieved October 31, 2025.
- ↑ "Dr. Tom Schmittgen named the V. Ravi Chandran Professor of Pharmaceutical Sciences". University of Florida. August 22, 2018. Retrieved October 31, 2025.
- ↑ "Dean Johnson and Dr. Schmittgen named 2020 AAAS Fellows". University of Florida. December 2, 2020. Retrieved October 31, 2025.
- ↑ Splett, Matthew (April 15, 2025). "UF pharmacy professor's paper ranks No. 2 in citations this century". University of Florida. Retrieved October 31, 2025.
External links
- Thomas D. Schmittgen publications indexed by Google Scholar